OGEN Stock Analysis: Buy, Sell, or Hold?
OGEN - Oragenics Inc.
$0.59
0.01 (1.73%)
▲
5d:
-5.77%
30d:
-0.34%
90d:
-13.45%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: May 08, 2026
0d
Get Alerted When OGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OGEN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: OGEN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: OGEN is currently trading at $0.59, which is considered slightly low relative to its 30-day fair value range of $0.58 to $0.61.
Technical Outlook: Technically, OGEN is in a strong downtrend. The price is currently testing key support at $0.57. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OGEN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.00 (+240.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OGEN is in a strong downtrend. The price is currently testing key support at $0.57. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OGEN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.00 (+240.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.58 -
$0.61
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 240.1% below Wall St target ($2.00)
- CAUTION: 5-day price weakness (-5.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.58 -
$0.61
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.58
Resistance Level
$0.65
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.85
Wall Street Target
$2.00
(+240.1%)
Revenue Growth (YoY)
-91.3%
Share & Embed Analysis
Last updated: June 24, 2026 7:08 AM ET
Data refreshes hourly during market hours. Next update: 8:08 AM
Data refreshes hourly during market hours. Next update: 8:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 57 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
12 analysts |
$139 | 65 BUY |
